40 min
JPM 2024: Pharma CEOs face a crossroads The MM+M Podcast
-
- Business
The 2024 J.P. Morgan Healthcare Conference is underway and Marc Iskowitz provides an update from on the ground in San Francisco. Jack O’Brien talks with Insilico Medicine President Michelle Chen about the company’s ongoing work to bring generative AI’s capabilities to the world of clinical research. Finally, Defense Secretary Lloyd Austin’s controversial prostate cancer treatment saga tops the Trends segment.
The 2024 J.P. Morgan Healthcare Conference is underway and Marc Iskowitz provides an update from on the ground in San Francisco. Jack O’Brien talks with Insilico Medicine President Michelle Chen about the company’s ongoing work to bring generative AI’s capabilities to the world of clinical research. Finally, Defense Secretary Lloyd Austin’s controversial prostate cancer treatment saga tops the Trends segment.
40 min